BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
61.37
+2.51 (4.26%)
At close: May 12, 2025, 4:00 PM
62.00
+0.63 (1.03%)
After-hours: May 12, 2025, 7:59 PM EDT
BioMarin Pharmaceutical (BMRN) Revenue by Segment
History
| Date | Voxzogo | Vimizom | Naglazyme | Palynziq | Aldurazyme | Brineura | Kuvan | Roctavian | Royalty and Other |
|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 795.70M | 724.30M | 487.90M | 371.90M | 197.60M | 170.30M | 109.70M | 36.60M | 43.98M |
| Dec 31, 2024 | 734.60M | 705.00M | 479.50M | 354.60M | 183.90M | 169.30M | 120.60M | 26.40M | 44.48M |
| Sep 30, 2024 | 672.30M | 704.40M | 467.80M | 342.40M | 187.60M | 164.90M | 129.30M | 18.10M | 45.90M |
| Jun 30, 2024 | 605.50M | 701.10M | 444.80M | 330.70M | 130.40M | 168.90M | 144.10M | 11.70M | 47.10M |
| Mar 31, 2024 | 534.90M | 677.50M | 402.90M | 317.30M | 132.10M | 161.70M | 166.10M | 4.30M | 47.80M |
| Dec 31, 2023 | 469.80M | 674.10M | 420.30M | 304.00M | 131.20M | 161.80M | 180.70M | 3.50M | 46.80M |
| Sep 30, 2023 | 390.90M | 669.90M | 422.50M | 288.50M | 126.20M | 160.80M | 197.60M | 800.00K | 45.70M |
| Jun 30, 2023 | 316.20M | 663.80M | 413.10M | 275.80M | 141.40M | 157.60M | 211.70M | - | 44.60M |
| Mar 31, 2023 | 237.30M | 668.20M | 438.80M | 262.50M | 138.40M | 157.20M | 218.70M | - | 50.10M |
| Dec 31, 2022 | 169.20M | 649.40M | 443.80M | 255.00M | 128.40M | 154.30M | 227.50M | - | 53.90M |
| Sep 30, 2022 | 108.10M | 647.90M | 426.40M | 246.50M | 110.90M | 149.10M | 242.40M | - | 56.50M |
| Jun 30, 2022 | 59.90M | 623.10M | 398.10M | 241.00M | 106.30M | 144.30M | 253.10M | - | 59.40M |
| Mar 31, 2022 | 25.50M | 609.20M | 401.10M | 238.30M | 97.10M | 136.90M | 274.30M | - | 58.30M |
| Dec 31, 2021 | 5.80M | 620.40M | 380.40M | 237.40M | 122.70M | 128.00M | 285.80M | - | 62.80M |
| Sep 30, 2021 | 100.00K | 565.40M | 417.00M | 223.20M | 103.70M | 125.60M | 306.40M | - | 63.30M |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.